GHK-Cu Liposomes in a Mouse Scald-Wound Model

Researchers encapsulated GHK-Cu in liposomes and evaluated the formulation in endothelial cells and a mouse scald-wound model.

Study design

The study assessed human umbilical-vein endothelial-cell proliferation and related protein expression before comparing liposomal and free GHK-Cu in burned mouse skin using wound timing and tissue markers.

What the researchers reported

The liposomal formulation increased endothelial-cell proliferation and was associated with stronger angiogenesis-related signals than free GHK-Cu in mice. The authors reported wound closure by day 14 in the experimental model.

What this result does not establish

This study tested a particular liposomal formulation, not GHK-Cu in every form. Mouse wound closure and cell-marker changes cannot establish human wound-healing outcomes or product equivalence.

This article summarizes one published study about GHK-Cu. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.